50
ADHD Dosing Has Two Failure Modes, and Trials Are Designed to Miss Both
(www.clinicaltrialvanguard.com)
this post was submitted on 13 Jun 2026
50 points (96.3% liked)
ADHD
13319 readers
7 users here now
A casual community for people with ADHD
Values:
Acceptance, Openness, Understanding, Equality, Reciprocity.
Rules:
- No abusive, derogatory, or offensive post/comments.
- No porn, gore, spam, or advertisements allowed.
- Do not request for donations.
- Do not link to other social media or paywalled content.
- Do not gatekeep or diagnose.
- Mark NSFW content accordingly.
- No racism, homophobia, sexism, ableism, or ageism.
- Respectful venting, including dealing with oppressive neurotypical culture, is okay.
- Discussing other neurological problems like autism, anxiety, ptsd, and brain injury are allowed.
- Discussions regarding medication are allowed as long as you are describing your own situation and not telling others what to do (only qualified medical practitioners can prescribe medication).
Encouraged:
- Funny memes.
- Welcoming and accepting attitudes.
- Questions on confusing situations.
- Seeking and sharing support.
- Engagement in our values.
Relevant Lemmy communities:
lemmy.world/c/adhd will happily promote other ND communities as long as said communities demonstrate that they share our values.
founded 3 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
Intensive dose management sounds like a great solution to the issues mentioned in the article - only problem is that requires more regular visits and reviews by doctors. That's both financially impossible for most patients, and frankly impossible to achieve widely with specialist shortages.
Yes and if I understand it correctly a point made in the arcticle is that studies often evaluate either on too rigid of a dosing management schedule or the dosing adjustment is unrealistically responsive to real world experience for people seeking ADHD medication.